Abstract
369 - The Cost of Adult Acute Lymphoblastic Leukemia Patients Treated with Blinatumomab with or without Bridging to Allo-HSCT in the US
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have